“ “We recently announced a partnership with Complement Pharmaceuticals to co-develop a complement inhibitor for neurodegenerative disorders, and our recent acquisition of Wilson Therapeutics fits perfectly within… ”
In Conversation
With over 30 years of experience in the life sciences industry, Angela McFarlane explains why the UK will not be removed from its position in the…
“ The UK is in itself a global life sciences hub and looked up to by the rest of the world. We have here the opportunity for… ”
“ I see technology as the enabler that creates new possibilities. Imaging devices are becoming more and more sophisticated and portable ”
“ We also collaborate on workshops with industry. There is a fundamental need to educate professionals about treatments and generate awareness of the patient view, and through… ”
“ It is this kind of contribution that has accelerated us to number five on the pharma UK rankings but quite frankly, working hard every day to… ”
“ “The UK is an international bridge and provides access to Europe, America and Asia. Its Commonwealth history and global presence have substantial advantages. Besides its location… ”
“ We are all proud of the work we do to help the amazing people who are affected by rare disease and yet continue to strive for… ”
“ "Today, our three sites are thus very complementary, we do not single out a lead site. In Japan we continue enhancing our technical development, while we… ”
“ "The philosophy behind the Cobra development is to work closely with our customers and expand through their future commitment to support shareholder investment and government grants." ”
“ "The regulatory environment we encountered has been unbelievably helpful ... To us, a good relationship with authorities, based on dialogue and understanding is essential, because it… ”
“ We do see a will and an intent from stakeholders, from government to physician groups, for the UK to be a global leader in life sciences.… ”
